Literature DB >> 18369735

The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age.

Anders Wikby1, Ingrid A Månsson, Boo Johansson, Jan Strindhall, Sven E Nilsson.   

Abstract

Earlier we identified an Immune Risk Profile (IRP) of very old individuals, 86-94 years of age, characterised by an inverted CD4/CD8 ratio and associated with persistent cytomegalovirus infection and an increase in the numbers of CD3+CD8+CD28- cells. In the present study we included data from a population-based sample in the age range of 20-79 years to examine the prevalence of individuals with an inverted CD4/CD8 ratio relative to age and gender across the entire adult lifespan. Immunological monitoring that was conducted included analysis of the numbers of T-cells in the subsets CD3+, CD3+CD4+, and CD3+CD8+ as well as CD3+CD8+CD28+, CD3+CD8+CD28-, and CD8+CD45RA+CCR7+. There was found to be a significant lowering of the numbers of CD3+, CD3+CD4+, and CD3+CD8+, and of the CD8+CD45RA+CCR7+ cells across the adult life-span. Notably, the prevalence of individuals with an inverted CD4/CD8 ratio increased from about 8% in the age range of 20-59 years to about 16% in the age range of 60-94 years. The mortality rate in individuals with an inverted CD4/CD8 ratio also increased significantly above the age of 60. Interestingly, the proportion of individuals with an inverted CD4/CD8 ratio was found to be significantly higher in men, whereas the numbers of CD3+CD4+ helper and CD8+CD45RA+CCR7+ naïve cells and the CD4/CD8 ratio were found to be significantly higher in women. These results highlight the importance of functioning of the thymus in the development of IRP and may partly account for the differences between sexes in terms of longevity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369735     DOI: 10.1007/s10522-008-9138-6

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  83 in total

Review 1.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

Review 2.  Immune cells have sex and so should journal articles.

Authors:  Sabra L Klein
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

Review 3.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

4.  Excess body mass is associated with T cell differentiation indicative of immune ageing in children.

Authors:  G Spielmann; C A Johnston; D P O'Connor; J P Foreyt; R J Simpson
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 5.  Sex-based differences in immune function and responses to vaccination.

Authors:  Sabra L Klein; Ian Marriott; Eleanor N Fish
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

6.  Aging affects the proportions of T and B cells in a group of elderly men in a developing country--a pilot study from Pakistan.

Authors:  Iftikhar Alam; David Goldeck; Anis Larbi; Graham Pawelec
Journal:  Age (Dordr)       Date:  2012-07-19

Review 7.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

8.  Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.

Authors:  S T Wright; K Petoumenos; M Boyd; A Carr; S Downing; C C O'Connor; M Grotowski; M G Law
Journal:  HIV Med       Date:  2012-10-04       Impact factor: 3.180

Review 9.  'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function.

Authors:  Paul Moss
Journal:  Med Microbiol Immunol       Date:  2019-05-03       Impact factor: 3.402

10.  BELFAST nonagenarians: nature or nurture? Immunological, cardiovascular and genetic factors.

Authors:  I M Rea
Journal:  Immun Ageing       Date:  2010-05-27       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.